Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11969461 Composition comprising botulinum toxin
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
February 28, 2017
0
Date of Patent
April 30, 2024
0
Patent Application Number
16079367
0
Patent Citations
US Patent 8444991 Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
0
US Patent 8563521 Biological active proteins having increased in vivo and/or in vitro stability
0
US Patent 8748151 Clostridial neurotoxins with altered persistency
0
US Patent 8808710 Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
0
US Patent 9050246 Injectable combination of adrenergic receptor agonists with fillers, for decreasing skin reactions due to injection
0
US Patent 9050336 None
0
US Patent 9161970 Dermal filler
0
US Patent 9260494 Biological active proteins having increased in vivo and/or in vitro stability
0
US Patent 9388394 Vaccines against clostridium difficile comprising recombinant toxins
0
US Patent 9622957 Dermal filler
0
•••
Patent Inventor Names
Hermann Russ
0
Peter Boderke
0
Klaus Fink
0
Harold Taylor
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11969461
0
Patent Primary Examiner
Louise W Humphrey
0
CPC Code
A61K 47/36
0
A61K 2800/91
0
A61K 9/19
0
A61K 31/728
0
A61P 21/00
0
A61K 8/64
0
A61Q 19/08
0
A61K 9/0019
0
A61K 9/08
0
A61K 38/4893
0
•••
Find more entities like US Patent 11969461 Composition comprising botulinum toxin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE